Literature DB >> 4613626

Acquired inhibitors in nonhemophilic patients.

K Lechner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4613626     DOI： 10.1159/000214043

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


× No keyword cloud information.
  18 in total

Review 1.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

2.  Acquired circulating anticoagulant in a 4-year-old child.

Authors:  P J Kirk; D S McLellan; A Aronstam
Journal:  Br Med J       Date:  1976-11-27

3.  Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors:  L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

4.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

5.  Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.

Authors:  J Rauch; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant.

Authors:  M Averbuch; Y Levo
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

Review 7.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease.

Authors:  U Dührsen; D Paar; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-01

8.  Acquired hemophilia in a patient with myeloma.

Authors:  L S Loftus; W N Arnold
Journal:  West J Med       Date:  1994-02

9.  The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.

Authors:  N E Anderson; M R Ali
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

10.  Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection.

Authors:  U Jaeger; S Kapiotis; I Pabinger; E Puchhammer; P A Kyrle; K Lechner
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.